TO-O-1004

N/A

Report date: 2023/08/11 09:49:30
NME

Base Information

Drug NameTO-O-1004
Drug Alias NameTO-O-1004
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPostoperative inflammationPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheratocular Biotek Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTheratocular Biotek Co Ltd
Inactive CompaniesN/A
Active IndicationsPostoperative inflammationPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A